PEGYLATED-INTERFERON AND RIBAVIRIN IN LIVER TRANSPLANT CANDIDATES AND RECIPIENTS WITH HCV CIRRHOSIS: SYSTEMATIC REVIEW AND META-ANALYSIS OF PROSPECTIVE CONTROLLED STUDIES

被引：0
|
作者：
Xirouchakis, Elias [1 ]
Triantos, Christos K. [1 ]
Manousou, Pinelopi [1 ]
Sigalas, Alexondros [1 ]
Calvaruso, Vincenza [1 ]
Corbani, Alice [1 ]
Patch, David W. [1 ]
Burroughs, Andrew K. [1 ]
机构：
[1] Royal Free Hosp, Royal Free Sheila Sherlock Liver Ctr, London NW3 2QG, England
来源：
HEPATOLOGY | 2008年 / 48卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
623
引用
收藏
页码：585A / 585A
页数：1
相关论文
共 50 条
  • [1] Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies
    Xirouchakis, E.
    Triantos, C.
    Manousou, P.
    Sigalas, A.
    Calvaruso, V.
    Corbani, A.
    Leandro, G.
    Patch, D.
    Burroughs, A.
    JOURNAL OF VIRAL HEPATITIS, 2008, 15 (10) : 699 - 709
  • [2] Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis
    Dolatimehr, Fardin
    Karimi-Sari, Hamidreza
    Rezaee-Zavareh, Mohammad Saeid
    Alavian, Seyed Moayed
    Behnava, Bita
    Gholami-Fesharaki, Mohammad
    Sharafi, Heidar
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 25
  • [3] Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis
    Fardin Dolatimehr
    Hamidreza Karimi-Sari
    Mohammad Saeid Rezaee-Zavareh
    Seyed Moayed Alavian
    Bita Behnava
    Mohammad Gholami-Fesharaki
    Heidar Sharafi
    DARU Journal of Pharmaceutical Sciences, 25
  • [4] Interleukin 2 Receptor Antagonists for Liver Transplant Recipients: A Systematic Review and Meta-Analysis of Controlled Studies
    Goralczyk, Armin D.
    Hauke, Nicola
    Bari, Narin
    Tsui, Tung Y.
    Lorf, Thomas
    Obed, Aiman
    HEPATOLOGY, 2011, 54 (02) : 541 - 554
  • [5] INTERLEUKIN 2 RECEPTOR ANTAGONISTS FOR LIVER TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CONTROLLED STUDIES
    Goralczyk, Armin D.
    Hauke, Nicola
    Bari, Narin
    Lorf, Thomas
    Obed, Aiman
    TRANSPLANT INTERNATIONAL, 2011, 24 : 86 - 87
  • [6] Sofosbuvir in combination with daclatasvir in liver transplant recipients with HCV infection: A systematic review and meta-analysis
    Liao, Haotian
    Tan, Ping
    Zhu, Zexin
    Yan, Xiaokai
    Huang, Jiwei
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (03) : 262 - 271
  • [7] Sofosbuvir and Ribavirin with or Without Pegylated-Interferon in Hepatitis C Virus Genotype-2 or -3 Infections: A Systematic Review and Meta-Analysis
    Bayatpoor, Mohammad Ehsan
    Khosravi, Mohammad Hossein
    Sharafi, Heidar
    Rezaee-Zavareh, Mohammad Saeid
    Behnava, Bita
    Alavian, Seyed Moayed
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2019, 14 (01):
  • [8] Role of polymorphisms of IL28B in HCV treatment effect of pegylated-interferon and ribavirin: a meta analysis
    Jia, Z. F.
    Jiang, J.
    Chi, X. M.
    Niu, J. Q.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S86 - S87
  • [9] STANDARD OR PEGYLATED INTERFERON WITH OR WITHOUT RIBAVIRIN TREATMENT OF HEPATITIS C AFTER LIVER TRANSPLANT: A META-ANALYSIS
    Papazian, Gregory K.
    HEPATOLOGY, 2008, 48 (04) : 897A - 897A
  • [10] Mycophenolate mofetil may induce prolonged severe anemia during pegylated-interferon/ribavirin/simeprevir therapy in liver transplant recipients
    Kogiso T.
    Tokushige K.
    Hashimoto E.
    Taniai M.
    Omori A.
    Kotera Y.
    Egawa H.
    Yamamoto M.
    Shiratori K.
    Clinical Journal of Gastroenterology, 2015, 8 (3) : 156 - 161
12345